BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 9, 2004
View Archived Issues
Nycomed terminates Oxygent license agreement
Read More
FDA approves new dosing options for Prevacid SoluTab
Read More
Chiron acquires Sagres Discovery
Read More
trans-ISA-247 completes single ascending dose study
Read More
End-of-phase II meeting held for HspE7
Read More
Icatibant awarded orphan drug status for edema in severe burn patients
Read More
U.S. phase I trial of Exherin cleared to begin
Read More
New oxymorphone ER trial protocol agreed under SPA
Read More
GOG submits IND for Xyotax study in ovarian cancer
Read More
DOV reaches agreement with FDA on clinical trial program for DOV diltiazem
Read More
Abbott and Celera form cancer therapeutics collaboration
Read More
Acusphere and Nycomed in European partnership for AI-700
Read More
MeNZB meningococcal B vaccine approved in New Zealand
Read More
Procter & Gamble license Geron's hTERT technology for research
Read More
Enrollment open in phase II Xolair peanut allergy study
Read More
Phase III study shows benefit of Bonviva/Boniva injection at extended intervals
Read More
Nebido completes European mutual recognition procedure
Read More
Histamine H3 receptor modulators claimed by Kyowa Hakko
Read More
Sponge-derived terpenoids reported by Galileo Laboratories
Read More
Tyrosine kinase inhibitors patented by Merck KGaA
Read More
ArQule describes lapachone analogues
Read More
Aminoalcohol derivatives for the treatment of urinary incontinence
Read More
AstraZeneca describes glucokinase activators
Read More
First clinical evidence of antitumor effects induced by taurolidine in glioblastoma
Read More
Potential of novel anxiolytic LY-544344
Read More
Antidepressant and anxiolytic properties of agomelatine
Read More
Anxiolytic effects of NK1 and CRF1 receptor antagonists in marmosets
Read More
Cellular process in cognition enhancement improved by 5-HT6 receptor antagonists
Read More
Antiviral nucleoside derivatives for the treatment of hepatitis C
Read More
